Families, lawmakers demand transparency for 89,000 drug
Families, lawmakers demand transparency for 89,000 drug
Get the Full StoryDeflazacort, a newly FDA-approved drug for Duchenne muscular dystrophy, has an 89,000-a-year price tag. It has been put on hold because of an uproar over drug prices.